Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Giant Biogene Holding Co. Ltd. ( (HK:2367) ) has shared an update.
Giant Biogene Holding Co., Ltd announced the completion of a Vendor Placing and Subscription of new shares under a general mandate. The company successfully placed 35,000,000 shares at HK$66.65 per share, raising approximately HK$2,294 million. The proceeds will be used to develop the company’s core business, including brand promotion, marketing, category expansion, and R&D investment, as well as to replenish liquidity and support general corporate purposes.
More about Giant Biogene Holding Co. Ltd.
Giant Biogene Holding Co., Ltd is a company incorporated in the Cayman Islands, primarily involved in the biotechnology industry. The company focuses on developing and expanding its product lines in Class III medical devices, feminine care products, and health products, with a strong emphasis on brand promotion and marketing to enhance its market presence.
YTD Price Performance: 54.51%
Average Trading Volume: 5,594,957
Technical Sentiment Signal: Sell
Current Market Cap: HK$78.84B
See more data about 2367 stock on TipRanks’ Stock Analysis page.